Global Human Growth Hormone market to grow at a CAGR of 4.22 percent by 2019

Global Human Growth Hormone Market 2015-2019 is a new market research publication announced by Reportstack. Growth hormone is a proteinaceous hormone consisting of 191 amino acid residues and is secreted by the anterior part of the pituitary gland. In children and adolescents, growth hormones are produced and secreted in high levels and promote linear growth. However, as an individual reaches the adult stage, its level starts declining and primarily perform anabolic functions. The direct activity of a human growth hormone, exerted via its interaction with the human growth hormone receptor, includes metabolic and anti-insulin activities. 
The analysts forecast that the Global Human Growth Hormone market to grow at a CAGR of 4.22 percent over the period 2014-2019. This report covers the present scenario and the growth prospects of the Global Human Growth Hormone market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of innovator human growth hormone drugs and their technologies. 
The report, Global Human Growth Hormone Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Growth Hormone market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
Key Vendors
• F. Hoffmann-La Roche
• Merck Serono
• Novo Nordisk
• Pfizer
Other Prominent Vendors
• Anhui Anke Biotechnology (Group)
• BioPartners
• Eli Lilly
• Ferring Pharmaceuticals
• GeneScience Pharmaceuticals
• Ipsen
• LG Life Sciences
• Sandoz International 
• Teva Pharmaceutical Industries

Complete report available @ Global Human Growth Hormone Market 2015-2019.